Breaking News

Evonik Boosts Portfolio of Nanoparticle Technologies

New nanoparticle process technology increases options for nanomedicine formulations.

Evonik, a contract development and manufacturing organization (CDMO) for complex parenterals, is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology. The copolymers (RESOMER RP d) are especially suited to nanoparticle formation and can be used in a wide range of parenteral drug delivery applications including controlled and sustained release drug products. Nanos...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters